Topic: Off-the-shelf Induced Pluripotent Stem Derived NK cells And TriKE Engagers To Treat Cancer

Jeffrey S. Miller, MD, received a Bachelor of Science degree from Northwestern University in Evanston, Illinois and received his MD from Northwestern University School of Medicine. He completed an internship and residency in Internal Medicine at the University of Iowa in Iowa City. After completing a post-doctoral fellowship in Hematology, Oncology and Transplantation at the University of Minnesota, he joined the faculty in 1991. Dr. Miller is currently a Professor of Medicine at the University of Minnesota. He is the Deputy Director of the University of Minnesota Masonic Comprehensive Cancer Center. He has more than 25 years of experience studying the biology of NK cells and other immune effector cells and their use in clinical immunotherapy with over 300 peer-reviewed publications. He is a member of numerous societies such as the American Society of Hematology, the American Association of Immunologists, a member of the American Society of Clinical Investigation since 1999. He serves on the editorial board for the Journal of Immunology and Transplantation and Cellular Therapy and is a reviewer for a number of journals and NIH grants. He is the recent recipient of the National Cancer Institute Outstanding Investigator Award for 2015 and a 2nd award in 2023.

Back to Speakers